CYTOVAC
Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a primary focus towards orphan diseases. The company is a leader in the rapidly developing field of individualized cell-based therapies for solid tumors, and is using the ALECSAT platform to generate best-in- class therapeutics to treat cancer with a high unmet medical need.
CYTOVAC
Industry:
Biotechnology Health Care
Founded:
2008-02-11
Address:
Hørsholm, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.cytovac.com
Total Employee:
11+
Status:
Active
Contact:
+45 45 57 22 45
Email Addresses:
[email protected]
Total Funding:
2.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
ERC-Belgium S.A.
Epitopoietic Research Corporation (ERC-Belgium SA) is a clinical stage emerging Biopharmaceutical Company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Official Site Inspections
http://www.cytovac.com
- Host name: linux11.dandomain.dk
- IP address: 93.191.158.16
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "CytoVac"
Cytovac | CytoVac A/S is a biotechnology company that is …
Jan 29, 2024 Cytovac is a growing Danish biotech company, which has chosen to focus on development of a cancer treatment that uses the body’s own immune system. Promising …See details»
The Company - Cytovac
Jan 29, 2024 Cytovac is a science driven biotech company also with capabilities of GMP production, running clinical trials, quality management and partnering R&D projects in the …See details»
CytoVac - Crunchbase Company Profile & Funding
Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a primary focus towards orphan diseases. The company is a leader in the rapidly developing field of …See details»
Cytovac – The Key to Immunotherapy
Feb 29, 2024 Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a primary focus towards orphan diseases. …See details»
Cytovac Company Profile 2024: Valuation, Funding & Investors
Cytovac General Information Description. Operator of a biotechnology company intended to focus on the development of cancer treatment. The company develops novel immunotherapies with …See details»
CytoVac - Contacts, Employees, Board Members, Advisors & Alumni
Organization. CytoVac . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. ... CytoVac has 4 …See details»
Cytovac Company Profile - Office Locations, Competitors ... - Craft
Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of immunotherapies with a primary focus on orphan diseases. The company is …See details»
CytoVac - Funding, Financials, Valuation & Investors - Crunchbase
Cytovac is a clinical-stage biopharmaceutical company. How much funding has this organization raised over time? ShowSee details»
Cytovac - Products, Competitors, Financials, Employees, …
Cytovac operates as a biotechnology company focused on the development of immunotherapy treatments for cancer. The company's main offering is the ALECSAT therapy, which involves …See details»
Cytovac | The Cytovac Team
Jan 29, 2024 The Cytovac Team. Tekst mangler. Scion DTU forskerparken; Venlighedsvej 6; DK-2970 Hørsholm; Denmark; Phone: +45 45 57 22 45; Email: [email protected]; Latest News. …See details»
CytoVac AB - LinkedIn
CytoVac AB | 926 followers on LinkedIn. Biotech company with Phase II Clinical Trials - ALECSAT - CAR-T cell therapy - Orphan Drug | Cytovac has the key to immunotherapy …See details»
ALECSAT - Wikipedia
ALECSAT (Autologous Lymphoid Effector Cells Specific Against Tumor cells) technology is a novel method of epigenetic cancer immunotherapy being used by the company CytoVac.It …See details»
CytoVac - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Cytovac is a clinical-stage biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
Cytovac - Overview, News & Competitors | ZoomInfo.com
Cytovac is a growing Danish biotech company, which has chosen to focus on development of a cancer treatment that uses the body's own immune system. Promising results gained by the …See details»
Vision and Conceptual Framework - Cytovac
Cytovac aims to secure financial funding for developing products for diseases with unmet needs. Cytovac’s ALECSAT platform is open for entering partnership agreements, both with academic …See details»
Cytovac Company Information - Funding, Investors, and More
The company Cytovac has raised a total of $2.24m in funding over 1 rounds. Key Insights: Unknown: $2.24m; 2019. Cytovac Unknown (2019, $2M) $2.24m. Discover Cytovac. …See details»
Cytovac raises $2.2M as it postpones its public listing.
Jul 4, 2019 Cytovac, a Hørsholm, Denmark-based biotech company working on immunology oncology solutions, announced closing a DKK 15M ($2.2M) capital investment round.. The …See details»
Partnership Strategy - Cytovac
Mar 15, 2024 Annual General Meeting – 28th of June 2024 – CytoVac AB May 31, 2024; Extraordinary General Meeting – 15 March 2024, in Malmö, Sweden – Cytovac AB February …See details»
Cytovation ASA - Targeted Tumor Membrane Immunotherapy
The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers. CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for …See details»
Pipeline - Cytovac
Email: [email protected]; Latest News. Annual General Meeting – 28th of June 2024 – CytoVac AB May 31, 2024; Extraordinary General Meeting – 15 March 2024, in Malmö, Sweden – …See details»